[Alemtuzumab-based HLA-haploidentical transplantation for relapsed/refractory aggressive NK-cell leukemia].

Komori Y, Kawata E, Yamaguchi J, Kawasumi N, Egashira A, Mizuhara K, Sasaki N, Tanabe YY, Kobayashi Y, Imadome KI, Watanabe A, Uoshima N

Open source

DOI: 10.11406/rinketsu.67.303
Published: 2026
Container: [Rinsho ketsueki] The Japanese journal of clinical hematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.11406/rinketsu.67.303,
  title = {[Alemtuzumab-based HLA-haploidentical transplantation for relapsed/refractory aggressive NK-cell leukemia].},
  author = {Komori Y and Kawata E and Yamaguchi J and Kawasumi N and Egashira A and Mizuhara K and Sasaki N and Tanabe YY and Kobayashi Y and Imadome KI and Watanabe A and Uoshima N},
  year = {2026},
  journal = {[Rinsho ketsueki] The Japanese journal of clinical hematology},
  doi = {10.11406/rinketsu.67.303},
  url = {https://doi.org/10.11406/rinketsu.67.303}
}

RIS

TY  - JOUR
TI  - [Alemtuzumab-based HLA-haploidentical transplantation for relapsed/refractory aggressive NK-cell leukemia].
AU  - Komori Y
AU  - Kawata E
AU  - Yamaguchi J
AU  - Kawasumi N
AU  - Egashira A
AU  - Mizuhara K
AU  - Sasaki N
AU  - Tanabe YY
AU  - Kobayashi Y
AU  - Imadome KI
AU  - Watanabe A
AU  - Uoshima N
PY  - 2026
JO  - [Rinsho ketsueki] The Japanese journal of clinical hematology
DO  - 10.11406/rinketsu.67.303
UR  - https://doi.org/10.11406/rinketsu.67.303
ER  -

APA

Y, K., E, K., J, Y., N, K., A, E., K, M., N, S., YY, T., Y, K., KI, I., A, W., & N, U. (2026). [Alemtuzumab-based HLA-haploidentical transplantation for relapsed/refractory aggressive NK-cell leukemia].. [Rinsho ketsueki] The Japanese journal of clinical hematology. https://doi.org/10.11406/rinketsu.67.303

Source records

pubmed · retrieved 2026-09-27T01:00:53.821Z